ACLX
Price
$67.16
Change
+$0.82 (+1.24%)
Updated
Jul 3 closing price
Capitalization
3.7B
43 days until earnings call
TGTX
Price
$36.72
Change
+$0.43 (+1.18%)
Updated
Jul 3 closing price
Capitalization
5.83B
30 days until earnings call
Interact to see
Advertisement

ACLX vs TGTX

Header iconACLX vs TGTX Comparison
Open Charts ACLX vs TGTXBanner chart's image
Arcellx
Price$67.16
Change+$0.82 (+1.24%)
Volume$166.18K
Capitalization3.7B
TG Therapeutics
Price$36.72
Change+$0.43 (+1.18%)
Volume$681.32K
Capitalization5.83B
ACLX vs TGTX Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. TGTX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ACLX: $67.16 vs. TGTX: $36.72)
Brand notoriety: ACLX and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 22% vs. TGTX: 30%
Market capitalization -- ACLX: $3.7B vs. TGTX: $5.83B
ACLX [@Biotechnology] is valued at $3.7B. TGTX’s [@Biotechnology] market capitalization is $5.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 2 bearish.
  • TGTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than TGTX.

Price Growth

ACLX (@Biotechnology) experienced а +3.69% price change this week, while TGTX (@Biotechnology) price change was -3.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.83B) has a higher market cap than ACLX($3.7B). TGTX YTD gains are higher at: 21.993 vs. ACLX (-12.427). TGTX has higher annual earnings (EBITDA): 70.5M vs. ACLX (-153.96M). ACLX has more cash in the bank: 543M vs. TGTX (132M). TGTX has less debt than ACLX: TGTX (8.98M) vs ACLX (53.2M). TGTX has higher revenues than ACLX: TGTX (386M) vs ACLX (76.8M).
ACLXTGTXACLX / TGTX
Capitalization3.7B5.83B63%
EBITDA-153.96M70.5M-218%
Gain YTD-12.42721.993-57%
P/E RatioN/A146.88-
Revenue76.8M386M20%
Total Cash543M132M411%
Total Debt53.2M8.98M593%
FUNDAMENTALS RATINGS
TGTX: Fundamental Ratings
TGTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXTGTX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
79%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETILX55.980.73
+1.32%
Eventide Gilead I
JFIFX19.420.20
+1.04%
JHancock Financial Industries I
ATGAX38.070.38
+1.01%
Cantor Fitzgerald Equity Opp A
TADGX83.080.58
+0.70%
T. Rowe Price Dividend Growth Advisor
SSHVX40.080.18
+0.45%
Sound Shore Institutional

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RNA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.24%
RNA - ACLX
59%
Loosely correlated
-0.65%
CGON - ACLX
58%
Loosely correlated
+0.82%
KRYS - ACLX
55%
Loosely correlated
+1.22%
BEAM - ACLX
53%
Loosely correlated
+0.65%
XNCR - ACLX
53%
Loosely correlated
+1.45%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.18%
ARRY - TGTX
36%
Loosely correlated
+11.93%
CLLS - TGTX
36%
Loosely correlated
N/A
AXON - TGTX
36%
Loosely correlated
+2.70%
ROIV - TGTX
36%
Loosely correlated
+0.18%
ACLX - TGTX
35%
Loosely correlated
+1.24%
More